A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19
Clinical trial NCT04627584 · UNKNOWN
Trial details
- NCT number
- NCT04627584
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-29
- Primary completion
- 2021-05-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.